Gene · 2271
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Renal cell carcinoma risk among individuals heterozygous for fumarate hydratase variants: further insights into genotype-phenotype correlations. | Hered Cancer Clin Pract | 2026 | 42120995 | PubTator, text mining | PubMed |
| Renal Cell Carcinoma With Concurrent Loss of SMARCB1/INI-1 and Fumarate Hydratase By Immunohistochemistry: A Case Report With Review of the Literature. | Appl Immunohistochem Mol Morphol | 2026 | 42084236 | PubTator, text mining | PubMed |
Intravascular propagation of adenomyosis within the blood vessels of the myometrium and uterine leiomyoma in a patient harboring germline mutation in the fumarate hydratase gene - a rare finding simulating malignancy. | Klin Onkol | 2026 | 42082369 | PubTator, text mining | PubMed |
| [Research progress on protein succination modification in cancer]. | Sheng Li Xue Bao | 2026 | 42014332 | PubTator, text mining | PubMed |
| Biochemical characterization of the FH variant p.Lys414Glu reveals loss of enzymatic function and disrupted multimerization. | Mol Genet Metab Rep | 2026 | 41918914 | PubTator, text mining | PubMed |
| High-Grade FDG Uptake of Fumarate Hydratase-Deficient Uterine Leiomyoma. | Clin Nucl Med | 2026 | 41911282 | PubTator, text mining | PubMed |
| Pck1 Deficiency Drives Mitochondrial Dysfunction and Cellular Senescence in Adipocytes. | Aging Cell | 2026 | 41910356 | PubTator, text mining | PubMed |
| Extracellular Vesicles Associated Metabolites as Intercellular Signalling Mediators in Disease and Therapy. | Metabolites | 2026 | 41893356 | PubTator, text mining | PubMed |
| Integrative Analysis of Post-Translational Modifications Identifies a PTM-Enriched Regulatory Core in Human Metabolic Enzymes. | Metabolites | 2026 | 41893314 | PubTator, text mining | PubMed |
| No Correlation Between Interferon Signaling and Cytosolic Mitochondrial DNA/RNA Leakage in Cultured Skin Fibroblasts of Patients With Mitochondrial Diseases. | Eur J Immunol | 2026 | 41891263 | PubTator, text mining | PubMed |
| Glioblastoma cells that evade chemoradiotherapy-induced cell death exhibit a bifurcated glycolytic program. | Cell Death Dis | 2026 | 41881949 | PubTator, text mining | PubMed |
| Short and Long Non-Coding RNAs in Renal Cell Carcinoma. | Noncoding RNA | 2026 | 41874142 | PubTator, text mining | PubMed |
| Cancer Metabolism and Its Historical & Molecular Foundations: An Overview. | Drugs Drug Candidates | 2026 | 41869637 | PubTator, text mining | PubMed |
| Clinical characteristics and follow-up of 77 patients with pathogenic fumarate hydratase variants. | BJU Int | 2026 | 41854143 | PubTator, text mining | PubMed |
| Progression after endoscopic treatment for type I gastric neuroendocrine tumors: A single-center retrospective study. | World J Gastroenterol | 2026 | 41809874 | PubTator, text mining | PubMed |
| Bilateral pheochromocytoma: case series and review of treatment strategies based on genetic mutations. | Transl Androl Urol | 2026 | 41809780 | PubTator, text mining | PubMed |
| Urinary Bladder Leiomyomas: A Clinicopathological Series With Hormone Receptor, HMGA2, 2SC, and Fumarate Hydratase Status Assessment. | Am J Surg Pathol | 2026 | 41808417 | PubTator, text mining | PubMed |
| Case Report: A patient with metastatic fumarate hydratase-deficient renal cell carcinoma associated with leiomyomatosis: real-world clinical insights on systemic therapy and liver-directed SBRT. | Front Oncol | 2026 | 41789002 | PubTator, text mining | PubMed |
| Mechanisms of PfDNMT2 inhibition and PfATP6-mediated resistance to the antimalarial candidate SC83288 in Plasmodium falciparum. | Nat Commun | 2026 | 41786780 | PubTator, text mining | PubMed |
| Fumarate loss destabilizes mitochondria and activates cGAS-STING in OLP. | Biomed Pharmacother | 2026 | 41775094 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2271/papers?page=2